2  SMITHKLINE ltSKB OPENS PLANT IN CHINA       PHILADELPHIA Oct 19    SmithKline Beckman Corp said it opened an 85 mln dlr pharmaceutical manufacturing plant in Tianjin China     The plant will make pharmaceutical products for the joint venture company Tianjin Smith Kline and French Laboratories     SmithKline said the joint venture combines Smith Kline and French Laboratories the pharmaceutical unit of SmithKline Beckman the ltTianjin Medical Co and ltHebel Chemical Plant in Tianjin     The plant has the capability to produce one billion tablets and 200 mln capsules a year  Reuter 3 